Expert Opinion on Drug Safety, Volume 22, Issue 11 (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 22, Issue 11 (2023)

See all volumes and issues
Vol 23, 2024 Volume 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Drug Safety Evaluation

Review Article
Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation
Luca Potestio, Elisa Camela, Sara Cacciapuoti, Fabrizio Martora, Luigi Guerriero, Luigi Fornaro, Angelo Ruggiero & Matteo Megna
Pages: 1003-1010
Published online: 28 Nov 2023
AbstractforEfficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation | Full Text | References | PDF (290.4 KB) | EPUB
  • 275 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
A safety review of current monoclonal antibodies used to treat multiple sclerosis
Gloria Dalla Costa & Giancarlo Comi
Pages: 1011-1024
Published online: 14 Jun 2023
AbstractforA safety review of current monoclonal antibodies used to treat multiple sclerosis | Full Text | References | PDF (389.9 KB) | EPUB
  • 326 Views
  • 1 CrossRef citations
  • 0Altmetric
Review Article
An updated safety review of the current drugs for managing ADHD in children
Erika Ryst & Ann Childress
Pages: 1025-1040
Published online: 28 Nov 2023
AbstractforAn updated safety review of the current drugs for managing ADHD in children | Full Text | References | PDF (424 KB) | EPUB
  • 426 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Balancing the risk of stroke and bleeding in atrial fibrillation patients with a history of falls
Nang Khaing Zar Latt, Peter Calvert & Gregory Y. H. Lip
Pages: 1041-1048
Published online: 28 Nov 2023
AbstractforBalancing the risk of stroke and bleeding in atrial fibrillation patients with a history of falls | Full Text | References | PDF (1.3 MB) | EPUB
  • 1517 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myeloma
Shonali Midha, Monique A. Hartley-Brown, Clifton C. Mo, Shahrier Hossain, Omar Nadeem, Elizabeth K. O’Donnell, Giada Bianchi, Adam S. Sperling, Jacob P. Laubach & Paul G. Richardson
Pages: 1049-1071
Published online: 28 Nov 2023
AbstractforA safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myeloma | Full Text | References | PDF (1.5 MB) | EPUB
  • 528 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Safety of current treatment options for NTRK fusion-positive cancers
Adeline T. Yang & Theodore Willis Laetsch
Pages: 1073-1089
Published online: 28 Nov 2023
AbstractforSafety of current treatment options for NTRK fusion-positive cancers | Full Text | References | PDF (1.5 MB) | EPUB
  • 210 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Antenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancy
Christian P Selinger, Konstantina Rosiou, Giacomo Broglio, Gillian Lever, Chun Ming Chiu, Linden J Stocker, Hlupekile Chipeta & Tracey Glanville
Pages: 1091-1097
Published online: 10 Jul 2023
AbstractforAntenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancy | Full Text | References | PDF (252.8 KB) | EPUB
  • 138 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Newly identified adverse events of enzalutamide using the food and drug administration adverse event reporting system
Xin Wang, Lina Chang, Zhenhua Li, Yuanfang Jiang, Yue Chen, Xinli Jia, Qiye Wang, Xiaolu Ren, Zhifang Ma & Wei Zhang
Pages: 1099-1103
Published online: 05 Sep 2023
AbstractforNewly identified adverse events of enzalutamide using the food and drug administration adverse event reporting system | Full Text | References | PDF (227.6 KB) | EPUB | Supplemental
  • 1305 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System
Vera Battini, Carla Carnovale, Emilio Clementi & Maurizio Sessa
Pages: 1105-1112
Published online: 12 Jun 2023
AbstractforUbrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System | Full Text | References | PDF (898.8 KB) | EPUB
  • 390 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Contributory factors and patient harm including deaths associated direct acting oral anticoagulants (DOACs) medication incidents: evaluation of real world data reported to the National Reporting and Learning System
Abdulrhman Al Rowily, Zahraa Jalal & Vibhu Paudyal
Pages: 1113-1125
Published online: 18 Jun 2023
AbstractforContributory factors and patient harm including deaths associated direct acting oral anticoagulants (DOACs) medication incidents: evaluation of real world data reported to the National Reporting and Learning System | Full Text | References | PDF (930.4 KB) | EPUB | Supplemental
  • 1163 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Cardiac arrhythmias associated with anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA Adverse Event Reporting System (FAERS)
Feifei Wang, Guishui Xu & Xinan Wu
Pages: 1127-1132
Published online: 10 Jul 2023
AbstractforCardiac arrhythmias associated with anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA Adverse Event Reporting System (FAERS) | Full Text | References | PDF (230.5 KB) | EPUB
  • 189 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
A real-world disproportionality analysis of ospemifene: data mining of the public version of FDA adverse event reporting system
Haixiao Wen, Chong Lu, Meng Zhang & Xingling Qi
Pages: 1133-1142
Published online: 24 Aug 2023
AbstractforA real-world disproportionality analysis of ospemifene: data mining of the public version of FDA adverse event reporting system | Full Text | References | PDF (779 KB) | EPUB | Supplemental
  • 121 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Seizures associated with antibiotics: a real-world disproportionality analysis of FAERS database
Dan Zou, Rui Zhang, Lei Yu, Tingting Hu & Bin Wu
Pages: 1143-1148
Published online: 13 Jul 2023
AbstractforSeizures associated with antibiotics: a real-world disproportionality analysis of FAERS database | Full Text | References | PDF (723.1 KB) | EPUB
  • 275 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles